RESÚMENES MAYO 2008

.

Schizophrenia-Psychotic Disorders & Antipsychotics

(Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

GRATIS = Texto gratuito en algunos países de la región iberoamericana (algunos artículos requieren ir a la tabla de contenidos del número actual de la revista)

 

3 - IQ tests as aids to diagnosis and management in early schizophrenia

Phil Harrison-Read

Advances in Psychiatric Treatment (2008) 14: 235-240

3! - Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study

James J. Newham, Simon H. Thomas, Karine MacRitchie, Patricia R. McElhatton, R. Hamish McAllister-Williams

The British Journal of Psychiatry (2008) 192: 333-337

GRATIS 3 - Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia

Gunnar Morken, Jan H Widen and Rolf W Grawe

BMC Psychiatry 2008, 8:32

 

3 - The possible involvement of metabotropic glutamate receptors in schizophrenia

Amir Krivoya, Corresponding Author Contact Information, E-mail The Corresponding Author, Tsvi Fischela, b and Abraham Weizmana, b, c

European Neuropsychopharmacology. Volume 18, Issue 6, June 2008, Pages 395-405

 

3 - Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: Role of serotonin 5-HT1A receptors

Hiroko Hagiwaraa, b, Yuko Fujitaa, Tamaki Ishimaa, Shinsui Kunitachia, Yukihiko Shirayamab, Masaomi Iyob and Kenji Hashimotoa, Corresponding Author Contact Information, E-mail The Corresponding Author

European Neuropsychopharmacology. Volume 18, Issue 6, June 2008, Pages 448-454

 

5 - Sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: A randomized double-blind pilot trial

Matthew J. Byerlya, Corresponding Author Contact Information, E-mail The Corresponding Author, Paul A. Nakoneznyb and A. John Rushc

Psychiatry Research. Volume 159, Issues 1-2, 30 May 2008, Pages 115-120

 

5< - Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction in schizophrenia: A 12-week double-blind, placebo-controlled pilot study

Trino Baptistaa, Corresponding Author Contact Information, E-mail The Corresponding Author, Euderruh Uzcáteguib, Nairy Rangelc, Yamily El Fakihb, Tatiana Galeazzid, Serge Beaulieue and Enma Araujo de Baptista

Psychiatry Research. Volume 159, Issues 1-2, 30 May 2008, Pages 250-253

 

3 - Olanzapine and risperidone block a high dose of methamphetamine-induced schizophrenia-like behavioral abnormalities and accompanied apoptosis in the medial prefrontal cortex

Tomohiro AbekawaCorresponding Author Contact Information, a, E-mail The Corresponding Author, Koki Itoa, Shin Nakagawaa, Yasuya Nakatoa and Tsukasa Koyama

Schizophrenia Research. Volume 101, Issues 1-3, April 2008, Pages 84-94

 

3! - An increased risk of stroke among young schizophrenia patients

Herng-Ching Lina, Fei-Hsiu Hsiaob, Stefani Pfeifferc, Yi-Ting Hwangd and Hsin-Chien Leee, f, Corresponding Author Contact Information, E-mail The Corresponding Author

Schizophrenia Research. Volume 101, Issues 1-3, April 2008, Pages 234-241

 

3! - Use of medications to reduce cardiovascular risk among individuals with psychotic disorders and Type 2 diabetes

Julie Kreyenbuhla, b, Corresponding Author Contact Information, E-mail The Corresponding Author, Deborah R. Medoffa, b, Stephen L. Seligerc and Lisa B. Dixona, b

Schizophrenia Research. Volume 101, Issues 1-3, April 2008, Pages 256-265

 

5 - Metabolic syndrome in first episode schizophrenia — A randomized double-blind controlled, short-term prospective study

Sahoo Saddichhaa, Corresponding Author Contact Information, E-mail The Corresponding Author, Narayana Manjunathab, Shahul Ameenc and Sayeed Akhtar

Schizophrenia Research. Volume 101, Issues 1-3, April 2008, Pages 266-272

 

4 - Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 1

Jonathan M. Meyera, b, Corresponding Author Contact Information, E-mail The Corresponding Author, Vicki G. Davisc, E-mail The Corresponding Author, Donald C. Goffd, e, E-mail The Corresponding Author, Joseph P. McEvoyf, g, E-mail The Corresponding Author, Henry A. Nasrallahh, E-mail The Corresponding Author, E-mail The Corresponding Author, Sonia M. Davisi, E-mail The Corresponding Author, Robert A. Rosenheckj, k, l, E-mail The Corresponding Author, Gail L. Daumitm, E-mail The Corresponding Author, John Hsiaon, E-mail The Corresponding Author, Marvin S. Swartzo, E-mail The Corresponding Author, T. Scott Stroupp, E-mail The Corresponding Authorand Jeffrey A. Lieberman

Schizophrenia Research. Volume 101, Issues 1-3, April 2008, Pages 273-286

 

3! - Early treatment-related changes in diabetes and cardiovascular disease risk markers in first episode psychosis subjects

Karen A. Grahama, Corresponding Author Contact Information, E-mail The Corresponding Author, Hyunsoon Chob, E-mail The Corresponding Author, Kimberly A. Brownleya, E-mail The Corresponding Authorand Joyce B. Harp

Schizophrenia Research. Volume 101, Issues 1-3, April 2008, Pages 287-294

 

3 - Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: A retrospective chart review

Marc De Herta, Corresponding Author Contact Information, E-mail The Corresponding Author, Vincent Schreursa, Kim Sweersa, Dominique Van Eycka, Linda Hanssensb, Sebastjan Šinkoc, Martien Wampersa, Andre Scheend, Joseph Peuskensa and Ruud van Winkela, e

Schizophrenia Research. Volume 101, Issues 1-3, April 2008, Pages 295-303

 

3 - Antipsychotic treatment patterns and hospitalizations among adults with schizophrenia

Susan dosReisa, b, Corresponding Author Contact Information, E-mail The Corresponding Author, Elizabeth Johnson